- Market Capitalization, $K 131,209
- Shares Outstanding, K 17,219
- Annual Sales, $ 0 K
- Annual Income, $ -6,560 K
- 60-Month Beta 2.52
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 6.97
|Period||Period Low||Period High||Performance|
| || |
+0.19 (+2.72%)since 01/24/20
| || |
+6.05 (+458.33%)since 11/22/19
| || |
+6.25 (+558.04%)since 02/22/19
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences
Multibagger stocks can make most of the bull run, courtesy of strong fundamentals and businesses that can multiply in a short span of time.
Zacks.com featured highlights include: Cassava Sciences, Rubicon Project, Talos Energy, Teekay Tankers and Karyopharm Therapeutics
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Companies in the news are: CMG, SAVA, RCON, IPHA
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
U.S. stocks rallied to attained fresh all-time highs in 2019, as the momentum continued in 2020. Here are five stocks that are poised to grow.
Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.
Top Ranked Momentum Stocks to Buy for December 10th
Here we discuss six small-cap companies with promising candidates in their pipeline for Alzheimer's disease.